Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy
Status:
Active, not recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This study aims to explore the effect of an adjuvant semi-individualized Chinese medicine
treatment plan on type 2 diabetic patients with stages 2 to 3 chronic kidney disease and
macroalbuminuria. This study will collect preliminary data on treatment effect, variance,
recruitment rate and attrition rate for the planning of a subsequent clinical trial.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
The University of Hong Kong
Collaborator:
School of Chinese Medicine, The University of Hong Kong